Wing Tech Inc.
9916 Newhall Rd.
Potomac, MD 20854
+1 301 660 8000
Wing Tech Inc.
101 Jefferson Dr.
Menlo Park, CA 94025
+1 650 943 3000
Wingtec GmbH
Im Rosengärtle 14
Karlsruhe, DE
+49 721 56044 900
Wing Tech Inc.
9916 Newhall Rd.
Potomac, MD 20854
+1 301 660 8000
Wing Tech Inc.
101 Jefferson Dr.
Menlo Park, CA 94025
+1 650 943 3000
Wingtec GmbH
Im Rosengärtle 14
Karlsruhe, DE
+49 721 56044 900
Helping life sciences innovators navigate complexity and realize opportunities
Get Started!Publications
Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on the TOBA II Study
Pietzsch JB, Geisler BP, Garner AM, Ryschon AM, Gray WA, Fujihara M, Schneider PA. Clinical and e...
Economics of drug-coated balloons for arteriovenous fistula stenosis in Japan and Korea based on the IN.PACT AV Access Trial
Chun HJ, Cao KN, Haruguchi H, Choi H, Yoshikawa M, Holden A, Pietzsch JB. Economics of drug-coate...
pDVI Cost-Effectiveness Study Published
May 28, 2021: Wing Tech analysis “Cost-Effectiveness of Percutaneous Deep Vein Arterialization ...
Wing Tech is an international technology and management consulting firm specializing in health-economic evidence development and strategic analysis for innovators in the global life sciences and medical technology sectors.
With more than two decades of experience, Wing Tech combines rigorous analytical methodologies with deep clinical and industry expertise to support evidence-based decision-making throughout the technology lifecycle. The firm serves a diverse client base, including Fortune 500 medical technology companies, leading research institutions, investors, and emerging life sciences ventures.
Wing Tech’s expertise and project experience span a broad range of clinical indications, diagnostic and therapeutic technologies, and healthcare systems worldwide.
Wing Tech applies rigorous analytical methodologies to generate evidence and inform strategic decision-making throughout the lifecycle of life sciences innovation.
Wing Tech’s peer-reviewed publications and scientific conference presentations contribute evidence and insights to inform clinical, economic, and strategic decision-making.
A health-economic analysis found transcatheter aortic valve replacement (TAVR) to be a cost-effective alternative to surgical valve replacement among patients at low surgical risk in the UK healthcare system.
May 3, 2025, Washington DC: Study lead author Dr. Sameh Sayfo (Baylor Scott & White Legacy Heart Center, Plano, TX) presented on the findings of a Wing Tech-led systematic search and meta-analysis of outcomes of endovascular treatment of long ...
May 2025, Paris, France: Prof. Andrew Sharp (University College Dublin, Ireland) will present “Cost-effectiveness of radiofrequency renal denervation in five European countries” at a session at EuroPCR 2025, the world-leading course in interve...
April 11, 2025, Blood Pressure: A country-specific cost-effectiveness analysis of radiofrequency renal denervation for Sweden has been published in Blood Pressure. The study, co-authored by Professors Thomas Kahan and Peter Lindgren (Karolinska I...
April 2, 2025, Nashville, TN: Study co-author Dr. Nicholas J. Petruzzi, MD, FSIR presented “One-Year Clinical and Lifetime Cost-Effectiveness Outcomes of Transcatheter Arterialization for No-Option CLTI in the U.S.” at the SIR 2025 Annual Meet...
May 19, 2022, Paris, France: “Projected Clinical Events Avoided in Patients Treated with Renal Denervation” to be presented by Prof. Roland Schmieder based on Wing Tech-developed analysis model. EuroPCR. http://pcronline.com/
Jan. 4, 2022: Study “Cost-Effectiveness of Urea Excipient-Based Drug-Coated Balloons for Chronic Limb-Threatening Ischemia from Femoropopliteal Disease in the Netherlands and Germany” published in Cardiovascular and Interventional Radiology.